YT, T., YW, W., TY, T., CY, L., SH, N., HY, K., . . . CT, L. (2025). Pathological primary tumor status, rather than adjuvant therapy, predicts survival outcomes in pT1-3N1M0 oral cavity squamous cell carcinoma: A nationwide cohort study. Oral oncology, 164, 107289. https://doi.org/10.1016/j.oraloncology.2025.107289
Chicago Style (17th ed.) CitationYT, Tsai, et al. "Pathological Primary Tumor Status, Rather than Adjuvant Therapy, Predicts Survival Outcomes in PT1-3N1M0 Oral Cavity Squamous Cell Carcinoma: A Nationwide Cohort Study." Oral Oncology 164 (2025): 107289. https://doi.org/10.1016/j.oraloncology.2025.107289.
MLA (9th ed.) CitationYT, Tsai, et al. "Pathological Primary Tumor Status, Rather than Adjuvant Therapy, Predicts Survival Outcomes in PT1-3N1M0 Oral Cavity Squamous Cell Carcinoma: A Nationwide Cohort Study." Oral Oncology, vol. 164, 2025, p. 107289, https://doi.org/10.1016/j.oraloncology.2025.107289.